Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immediate Release vs Extended Release Torsemide in Heart Failure
NCT06176794Phase 2Withdrawn
- Start
- Nov 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of torasemide in heart failure (HF). Planned start Nov 2024; status: withdrawn.
02
Drugs
torasemide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT06176794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06176794.